Charles Theuer Tracon Pharmaceuticals, Inc. (TCON) insider trading activity

Charles Theuer is PRESIDENT AND CEO of Tracon Pharmaceuticals, Inc.. Currently has a direct ownership of 406,417 shares of TCON, which is worth approximately $243,850. The most recent transaction as insider was on Nov 18, 2021, when has been sold 681 shares (Common Stock) at a price of $2.88 per share, resulting in proceeds of $1,961. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 406K

0% 3M change

1.75% 12M change

Total Value Held $243,850

CHARLES THEUER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 18 2021	BUY Open market or private purchase	$1,961 $2.88 p/Share	681 Added 0.31%	215,818 Common Stock
Nov 05 2021	BUY Open market or private purchase	$13,680 $3.42 p/Share	4,000 Added 1.83%	215,137 Common Stock
Aug 16 2021	BUY Open market or private purchase	$10,680 $3.56 p/Share	3,000 Added 1.42%	207,732 Common Stock
Jan 27 2021	BUY Open market or private purchase	$98,780 $8.98 p/Share	11,000 Added 5.18%	201,232 Common Stock
Dec 29 2020	BUY Open market or private purchase	$9,980 $9.98 p/Share	1,000 Added 0.52%	190,232 Common Stock
Oct 21 2020	BUY Open market or private purchase	$8,760 $4.38 p/Share	2,000 Added 1.05%	189,232 Common Stock

Also insider at

FDMT

4D Molecular Therapeutics, Inc. Healthcare

ONCT

Oncternal Therapeutics, Inc. Healthcare

Charles Theuer

PRESIDENT AND CEO

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCON shares.

Notify only if

Value

Insider Trading

Get notified when an Tracon Pharmaceuticals, Inc. insider buys or sells TCON shares.

Notify only if

Operation

Value

Type

News

Receive news related to Tracon Pharmaceuticals, Inc.

Track Activities on TCON

Account